Used extensively in the development of antibody-drug conjugates (ADCs) for targeted cancer therapy. It serves as a linker molecule, connecting cytotoxic agents like DM4 to monoclonal antibodies, ensuring precise delivery to cancer cells. This enhances the efficacy of the treatment while minimizing damage to healthy tissues. Its application is crucial in improving the therapeutic index of ADCs, making it a key component in modern oncology research and drug development.